Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 147 M133 M153 M-126 M64 M 224 M Research & development ————— — Operating income -311 M-237 M-189 M211 M-7 M -222 M Non-Operating Income, Total 21 M12 M14 M17 M13 M 56 M Interest expense, net of interest capitalized 786 M754 M701 M591 M542 M 2.59 B Non-Operating Income, excl. Interest Expenses -765 M-742 M-687 M-574 M-529 M -2.53 B Unusual income/expense ————— — Pretax income -121 M-81 M-41 M45 M32 M -45 M Equity in earnings ————— — Taxes -21 M-11 M-5 M16 M11 M 11 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -100 M-70 M-36 M29 M21 M -56 M Discontinued operations ————— — Net income -100 M-70 M-36 M29 M21 M -56 M Dilution adjustment 00000 0 Preferred dividends 8 M8 M9 M8 M8 M 33 M Diluted net income available to common stockholders -108 M-78 M-45 M21 M13 M -89 M Basic earnings per share (Basic EPS) -0.26-0.19-0.110.060.03 -0.21 Diluted earnings per share (Diluted EPS) -0.26-0.19-0.110.060.03 -0.21 Average basic shares outstanding -830.69 M415.13 M415.56 M415.33 M416.15 M — Diluted shares outstanding -830.69 M415.13 M415.56 M415.33 M466.55 M — EBITDA -1.07 B-894 M-804 M-263 M-513 M -2.47 B EBIT -1.06 B-961 M-865 M-380 M-548 M -2.75 B Cost of revenue 79 M64 M38 M3 M0 105 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) -10 M67 M61 M117 M35 M 280 M